Sign in

Alzheimer disease: trials that stopped early

Trials on Alzheimer disease that stopped early, each with the reason the sponsor wrote in the registry, quoted word for word. Next to them: finished trials whose registry record links a result paper.

Stopped early

86 stopped trials give a reason in the registry, latest registry update first.

  1. Withdrawn

    Pre-Pilot: Problem Adaptation THerapy in Caregivers

    Reason given in the registry

    “Study not started, investigators opted to focus on other projects.”

    Quoted unchanged from ClinicalTrials.gov; record updated 31 Jan 2025.

    Ended
    Dec 2025
    Run by
    Weill Medical College of Cornell University
    Registry record
    NCT05567120
  2. Withdrawn

    Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study

    Reason given in the registry

    “Not realisable on time planned and with the academic funds”

    Quoted unchanged from ClinicalTrials.gov; record updated 27 Jan 2025.

    Ended
    Oct 2026
    Run by
    Erasme University Hospital
    Registry record
    NCT06391853
  3. Terminated

    Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease

    Reason given in the registry

    “Due to the inability to complete subject enrollment and follow-up as originally scheduled, coupled with funding shortages and overall strategic adjustments from the sponsor, the study was terminated on November 12, 2024.”

    Quoted unchanged from ClinicalTrials.gov; record updated 4 Dec 2024.

    Ended
    Nov 2024
    Phase
    Phase 2
    Run by
    Capital Medical University
    Registry record
    NCT05670912
  4. Withdrawn

    Voice and Swallowing Disorders in Adults With and Without Alzheimer's Disease

    Reason given in the registry

    “Change of scope of the work given feedback from funding agency leading to new IRB/clinicaltrials.gov registration.”

    Quoted unchanged from ClinicalTrials.gov; record updated 7 Nov 2024.

    Ended
    Nov 2024
    Run by
    Vanderbilt University Medical Center
    Registry record
    NCT06328374
  5. Withdrawn

    Meaningful Aspects of Health for Adults With Dementia, Their Care Partners and Healthcare Practitioners

    Reason given in the registry

    “Submission to EC abandonned”

    Quoted unchanged from ClinicalTrials.gov; record updated 19 Sept 2024.

    Ended
    Mar 2025
    Run by
    Centre Hospitalier Universitaire de Nice
    Registry record
    NCT06242574
  6. Terminated

    Biological Sample Collection for Research and Biobanking

    Reason given in the registry

    “The study was voluntarily terminated by the PI to focus efforts on an alternative biobanking protocol.”

    Quoted unchanged from ClinicalTrials.gov; record updated 2 Aug 2024.

    Ended
    Nov 2023
    Run by
    New York Stem Cell Foundation Research Institute
    Registry record
    NCT04270604
  7. Terminated

    Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome

    Reason given in the registry

    “COVID delayed study timelines. Competing studies began enrolling at our sites.”

    Quoted unchanged from ClinicalTrials.gov; record updated 27 Jun 2024.

    Ended
    Apr 2024
    Run by
    LuMind IDSC Foundation
    Registry record
    NCT04149197
  8. Terminated

    A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.

    Reason given in the registry

    “Part I: Open-label was completed.”

    Quoted unchanged from ClinicalTrials.gov; record updated 27 Jun 2024.

    Ended
    Mar 2024
    Run by
    M. H MediCane Ltd.
    Registry record
    NCT06217146
  9. Terminated

    Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension

    Reason given in the registry

    “Study only continued to 2 year follow-up.”

    Quoted unchanged from ClinicalTrials.gov; record updated 14 Jun 2024.

    Ended
    Jun 2024
    Run by
    Novoic Limited
    Registry record
    NCT04846426
  10. Terminated

    Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension

    Reason given in the registry

    “Study only continued to 2 year follow-up.”

    Quoted unchanged from ClinicalTrials.gov; record updated 14 Jun 2024.

    Ended
    May 2024
    Run by
    Novoic Limited
    Registry record
    NCT04951284
  11. Withdrawn

    WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease

    Reason given in the registry

    “funding purposes”

    Quoted unchanged from ClinicalTrials.gov; record updated 13 May 2024.

    Ended
    Mar 2024
    Run by
    Scion NeuroStim
    Registry record
    NCT05032482
  12. Terminated

    PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand

    Reason given in the registry

    “PI closed the protocol due to low recruitment”

    Quoted unchanged from ClinicalTrials.gov; record updated 1 May 2024.

    Ended
    Dec 2023
    Phase
    Phase 1
    Run by
    National Institute of Mental Health (NIMH)
    Registry record
    NCT03958630
  13. Terminated

    Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease

    Reason given in the registry

    “Insufficient Recruitment”

    Quoted unchanged from ClinicalTrials.gov; record updated 10 Apr 2024.

    Ended
    Mar 2024
    Phase
    Phase 1
    Run by
    German Center for Neurodegenerative Diseases (DZNE)
    Registry record
    NCT03056495
  14. Withdrawn

    Intermittent Oral-esophageal Tube Feeding in Alzheimer's Patients With Dysphagia

    Reason given in the registry

    “ethical issues”

    Quoted unchanged from ClinicalTrials.gov; record updated 5 Mar 2024.

    Ended
    Aug 2024
    Run by
    Zeng Changhao
    Registry record
    NCT06220292
  15. Terminated

    Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD)

    Reason given in the registry

    “The study was terminated after completing the dose escalation portion of the study. The expansion cohort was not initiated to conduct a global trial based on the approved US IND using a new manufacturing process.”

    Quoted unchanged from ClinicalTrials.gov; record updated 1 Mar 2024.

    Ended
    Jan 2024
    Phase
    Phase 1
    Run by
    NKGen Biotech, Inc.
    Registry record
    NCT04678453
  16. Withdrawn

    Toolkit for Experiential Well-beiNg in Dementia (TEND)

    Reason given in the registry

    “We are withdrawing our study due to regulatory requirements from our funding source.”

    Quoted unchanged from ClinicalTrials.gov; record updated 22 Feb 2024.

    Ended
    Apr 2024
    Run by
    Massachusetts General Hospital
    Registry record
    NCT06257563
  17. Withdrawn

    Videoconferencing Acceptance and Commitment Therapy With a Web App Use for Family Caregivers of People With Dementia

    Reason given in the registry

    “We changed our plan.”

    Quoted unchanged from ClinicalTrials.gov; record updated 5 Jan 2024.

    Run by
    University of Alabama at Birmingham
    Registry record
    NCT05518968
  18. Withdrawn

    A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

    Reason given in the registry

    “Study replaced with a new study”

    Quoted unchanged from ClinicalTrials.gov; record updated 14 Apr 2023.

    Ended
    Feb 2024
    Phase
    Phase 3
    Run by
    Cerecin
    Registry record
    NCT04187547
  19. Withdrawn

    Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior

    Reason given in the registry

    “PI withdrawn”

    Quoted unchanged from ClinicalTrials.gov; record updated 22 Mar 2023.

    Ended
    Oct 2024
    Run by
    Weill Medical College of Cornell University
    Registry record
    NCT03149380
  20. Suspended

    A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

    Reason given in the registry

    “The quality of study was seriously affected by the COVID-19, so it was decided to suspend the trial and restart it at the right time.”

    Quoted unchanged from ClinicalTrials.gov; record updated 23 Nov 2022.

    Ended
    Oct 2026
    Phase
    Phase 3
    Run by
    Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
    Registry record
    NCT04520412
  21. Withdrawn

    A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia

    Reason given in the registry

    “Study withdrawn and being modified under another protocol”

    Quoted unchanged from ClinicalTrials.gov; record updated 17 Nov 2022.

    Ended
    Dec 2024
    Run by
    Mayo Clinic
    Registry record
    NCT05497817
  22. Withdrawn

    Acupuncture Treatment for Improving Alzheimer's Dementia

    Reason given in the registry

    “due to covid19 pandemic”

    Quoted unchanged from ClinicalTrials.gov; record updated 12 Oct 2022.

    Run by
    N & S Neurology Center, A Medical Group, Inc
    Registry record
    NCT04064021
  23. Withdrawn

    Lymphatic System Health in Alzheimer's Disease

    Reason given in the registry

    “Pending COVID-19 pandemic”

    Quoted unchanged from ClinicalTrials.gov; record updated 28 Sept 2022.

    Ended
    Dec 2023
    Phase
    Phase 1
    Run by
    Neurological Associates of West Los Angeles
    Registry record
    NCT04205539
  24. Withdrawn

    A Study of ACI-24 in Adults With Down Syndrome

    Reason given in the registry

    “decision to proceed with an optimized study design and optimized vaccine formulation”

    Quoted unchanged from ClinicalTrials.gov; record updated 22 Oct 2021.

    Ended
    Oct 2024
    Phase
    Phase 2
    Run by
    AC Immune SA
    Registry record
    NCT04373616
  25. Withdrawn

    Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease

    Reason given in the registry

    “Funding ran out before study started, prior PI left institution.”

    Quoted unchanged from ClinicalTrials.gov; record updated 16 Sept 2020.

    Ended
    Jul 2025
    Phase
    Phase 2
    Run by
    Palo Alto Veterans Institute for Research
    Registry record
    NCT02500784
  26. Withdrawn

    Biomarkers in Neurodegenerative Diseases

    Reason given in the registry

    “Lack of regulatory approval”

    Quoted unchanged from ClinicalTrials.gov; record updated 12 Nov 2019.

    Ended
    Oct 2025
    Run by
    University of Minnesota
    Registry record
    NCT04055532

Sources: ClinicalTrials.gov and the EU Clinical Trials Register. Status, reason, dates and result links are registry fields, shown as the registry gives them.